Granted Patents

  • Herrera Sanchez MB, Tapparo M, Saccu G. A method of qualifying as pharmaceutically active a batch of undifferentiated adult stem cells having the potential to differentiate along the hepatic lineage. 230038EP01 - UNICYTE AG - Filing report of EP appln. 23201384.7 // Our Ref.: (E0147528).

  • Robbins P.; Camussi G.; Herrera Sanchez MB. Extracellular vesicles from human liver stem cells (HLSC-EVs) for reducing cellular senescence. Priority number(s): EP2020065986W·2020-06-09; WO2020249567A1.

  • Herrera Sanchez MB, Fonsato V., Bruno S., Tetta C., Camussi G. Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease. Priority number(s): EP20100425052 20100302; WO2011EP52945 20110228; EP20110705585 20110228

  • Bruno S, Herrera Sanchez MB, Fonsato V, Camussi G, Tetta C. Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease. Priority number(s): EP20100425052 20100302; WO2011EP52945 20110228; EP20110705585 20110228

  • Herrera Sanchez MB, Fonsato V., Tetta C., Camussi G. Conditioned medium of liver progenitor cells. Priority number(s): EP20080010651 20080611; WO2009EP57232 20090611

  • Herrera Sanchez MB, Bussolati B, Camussi G, Buttiglieri S. Liver progenitor cells. Priority     number(s) WO2006126219A8; WO2006126236A1

  • Camussi Giovanni, Bruno Stefania, Bussolati Benedetta (2011). “Isolated multipotent mesenchymal stem cells from human adult glomeruli (HGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney”. US2011256111 (A1), EP2186883 (A1).